Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
489 INR | +0.78% | +5.75% | -0.19% |
05-06 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 | |
05-03 | Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Sales 2024 | 25.29B 303M 413M | Sales 2025 * | 27.64B 331M 451M | Capitalization | 44.67B 535M 729M |
---|---|---|---|---|---|
Net income 2024 | 1.71B 20.54M 27.99M | Net income 2025 * | 2.38B 28.46M 38.78M | EV / Sales 2024 | 1.58 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 |
23.4
x | P/E ratio 2025 * |
19
x | Employees | 1,003 |
Yield 2024 * |
0.97% | Yield 2025 * |
1.32% | Free-Float | 36.93% |
Latest transcript on Aarti Drugs Limited
1 day | +0.64% | ||
1 week | +5.75% | ||
Current month | -3.23% | ||
1 month | -0.83% | ||
3 months | -9.78% | ||
6 months | +3.64% | ||
Current year | -0.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 12-07-05 |
Rushikesh Deole
CMP | Compliance Officer | - | 19-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Director/Board Member | 61 | 87-01-01 | |
Director/Board Member | 60 | 95-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 489 | +0.78% | 41 199 |
24-05-16 | 485.2 | +1.01% | 55,033 |
24-05-15 | 480.3 | +1.34% | 66,341 |
24-05-14 | 474 | +0.47% | 58,580 |
24-05-13 | 471.8 | +2.18% | 76,587 |
Delayed Quote NSE India S.E., May 17, 2024 at 03:52 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+30.74% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.45% | 239B | |
+10.07% | 209B | |
-3.11% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock